M Holdings Securities Inc. recently acquired 11,373 new shares of Deere & Company, valued at approximately $5.3 million, during the fourth quarter. Deere & Company reported strong fiscal Q1 results, exceeding earnings and revenue expectations, and declared a quarterly dividend of $1.62 per share. Analysts currently rate the stock as a "Moderate Buy" with an average price target of $639.58.

M Holdings Securities Inc. has acquired 67,447 shares of Verizon Communications Inc., valued at approximately $2.75 million, establishing a new position in the company during the fourth quarter. Verizon recently exceeded earnings estimates with $1.28 per share and reported a 2.7% increase in revenue, while maintaining an attractive 6.0% dividend yield for income investors. The stock is currently rated as a "Moderate Buy" by analysts, with a consensus price target of $50.59.

M Holdings Securities Inc. has made a new $8.26 million investment in Merck & Co., Inc. by purchasing 78,499 shares during the fourth quarter. Institutional ownership of Merck remains high at 76.07%, with several other firms also increasing their stakes. Analysts maintain a "Moderate Buy" rating for Merck, with recent positive news including a Wells Fargo "Buy" rating and encouraging Phase III HIV data, despite a setback in a lung cancer trial.

M Holdings Securities Inc. has acquired a new stake in Qualcomm, purchasing 17,904 shares valued at $3.06 million during the fourth quarter. Qualcomm is gaining institutional interest, with a significant 74.35% of its stock held by institutions, and it is expanding its reach into AI and edge-computing markets. Despite these positive strategic developments, the stock is currently rated as a "Hold" by analysts and is experiencing weakness due to a broader semiconductor selloff.

M Holdings Securities Inc. has made a new $2.25 million investment in PayPal Holdings, Inc. by purchasing 38,467 shares in the fourth quarter. Despite PayPal beating earnings estimates with an EPS of $1.34 and revenue up 7.2% year over year, the stock is currently rated a "Hold" by analysts and is trading near its 52-week low. The company recently announced a new quarterly dividend of $0.14 per share, but concerns about growth story versus deep-value play persist among investors.

M Holdings Securities Inc. has invested $3.99 million in The Walt Disney Company (NYSE:DIS) by purchasing 35,071 shares during the fourth quarter. This move reflects continued institutional interest in Disney, with other major firms like Vanguard and State Street also increasing their stakes. Wall Street analysts generally hold a positive outlook for Disney, with several raising price targets and the company recently exceeding quarterly earnings and revenue estimates.

Evercore ISI has increased its price target for Humana (HUM) to $370 from $250, while maintaining an "In Line" rating for the stock. This adjustment comes amidst other analyst revisions for Humana, with some firms raising price targets and others maintaining or even lowering ratings in recent days. Humana's stock performance and various analyst recommendations are detailed, along with company profile and financial data.

WINTON GROUP Ltd significantly reduced its stake in Kenvue Inc. by selling 203,015 shares, decreasing its holdings by 85.1% to 35,418 shares. This comes as Kenvue reported better-than-expected earnings and continues to offer a substantial dividend yield of 4.6%. Analysts currently maintain a "Hold" rating for the stock with a consensus target price of $19.33.

Inceptionr LLC significantly increased its stake in Cummins Inc. (NYSE:CMI) by 108.5% in the fourth quarter, now holding 3,593 shares valued at approximately $1.83 million. The article notes positive sentiment from Wall Street analysts, with UBS upgrading the stock and several firms raising price targets, leading to a consensus "Moderate Buy" rating. Cummins also reported strong first-quarter earnings, exceeding estimates, and announced a quarterly dividend of $2.00 per share.

Merck Animal Health has announced an agreement to acquire TARGAN, a biodevice solutions developer specializing in the poultry industry, for an undisclosed sum. The acquisition is expected to close in Q3 2026 and aims to integrate TARGAN's automated gender identification technology.